MedPath

Evaluation of iPRF With Vit.D As an Adjunct to Non-Surgical Therapy in the Treatment of Stage III Periodontitis

Phase 2
Not yet recruiting
Conditions
Periodontal Pocket
Interventions
Procedure: PMPR only
Procedure: PMPR+iPRF
Drug: PMPR+iPRF+Vit.D
Registration Number
NCT06570200
Lead Sponsor
Cairo University
Brief Summary

a clinical trial will be made to investigate the effect of locally applied injectable prf (iPRF) plus vitamin D on the periodontal pockets in stage III periodontitis patients

Detailed Description

in this clinical trial, the treatment of periodontal pockets in stage III periodontitis patients will be evaluated. the study participants will be divided in 3 groups:

First group \>\> will be treated with professional mechanical plaque removal (PMPR) only.

second group \>\> will be treated with PMPR + locally applied iPRF.

Third group \>\> will be treated with PMPR + locally applied iPRF + vitamin D.

Then the results will be compared after 6 months of the treatment (clinically and radiographically).

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  1. Patients with healthy systemic condition.
  2. Adult patients ˃ 18 years old.
  3. Patients with Stage III periodontitis.
  4. Patients accept 3-month follow-up period (cooperative patients).
  5. Patients provide an informed consent.
Exclusion Criteria
  1. Presence of prosthetic crowns.
  2. Extensive interproximal restorations.
  3. Periodontal therapy within the last 12 months.
  4. Having undergone surgical periodontal therapy or undergoing orthodontic treatment.
  5. Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis.
  6. The use of antibiotics or anti-inflammatory drugs 3-month prior to the procedure and till the end of 6-month of follow-up.
  7. Smokers.
  8. Pregnant females.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
PMPR onlyPMPR onlyscaling and root planing only will be made for group 1 (control group)
PMPR + iPRFPMPR+iPRFscaling and root planing plus locally applied iPRF in the periodontal pocket will be made for test group 1.
PMPR + iPRF + Vit.DPMPR+iPRF+Vit.Dscaling and root planing plus locally applied iPRF and vitamin D in the periodontal pocket will be made for test group 2. vitamin D will be obtained from a commercial product in the Egyptian pharmacies called (Devarol S) in the form of injectable ampoules containing 200000 IU of cholecalciferol (2.5 mg/ml)
Primary Outcome Measures
NameTimeMethod
pocket depth reduction6 months

estimate the amount of reduction of the pocket depth from baseline and after 6 months of treatment

Secondary Outcome Measures
NameTimeMethod
clinical attachment level (CAL) gain6 months

the amount of CAL gained from baseline and after 6 months of treatment

Plaque index6 months

comparison of amount of plaque before and after treatment using plaque score

Gingival Marginal Level (GML)6 months

determining the location of gingival margin in relation to the tooth before and after treatment

Post-operative Pain6 months

comparing the pain before and after treatment using Visual Analogue Scale(VAS) Questionnaire. A scale from 0-10 will be used with 0 means no pain and 10 means maximum pain.

Treatment time taken for each groups6 months

a timer will be used to determine the required time of each procedure of the 3 study groups

degree of bone fill or loss6 months

using digital software, evaluation of the radiographic changes will be done at the area diagnosed with periodontal problem and selected for the treatment before and after the intervention.

Bleeding on probing (BOP)6 months

measuring the percentage of BOP using a periodontal probe before and after treatment

© Copyright 2025. All Rights Reserved by MedPath